cro.directory
← Compare landing

Esco Aster vs IPM Biotech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/escoaster/ipmbiotech

CategoryEsco AsterIPM Biotech
Listed sitebothcro
SummaryEsco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.IPM Biotech (生创精准医疗科技有限公司) is a cell technology and regenerative medicine company founded in 2015 by a team of renowned returnee scientists specializing in stem cells and regenerative medicine.
Services
  • Translational Research
  • Clinical Trial Services
  • GLP Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • Translational Research
  • Clinical Trial Services
  • Protein Engineering
  • Discovery Research
Modalities
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Cell Therapy
Indications
  • Neurology
  • Infectious Disease
  • Respiratory
  • Dermatology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
LocationsData not yet provided.
  • Headquarters, Hangzhou, Zhejiang, China
  • Xiaoshan Office, Hangzhou, Zhejiang, China
  • Gongshu Office, Hangzhou, Zhejiang, China
  • Zhoushan Facility, Zhoushan, Zhejiang, China
  • Boao Facility, Qionghai, Hainan, China
  • Bangkok Facility, Bangkok, Bangkok, Thailand
  • Chongqing, Chongqing, Chongqing, China
  • Jinan, Jinan, Shandong, China
  • Zhengzhou, Zhengzhou, Henan, China
  • Hong Kong, Hong Kong, Hong Kong, Hong Kong
Certifications
  • cGMP · Identifier: cGMP-compliant
  • GLP · Identifier: GLP Toxicology
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.